Global Team Identifies Highlights Across Pharmaceutical/Biotechnology, Diagnostics, and Research Industries.
laboratories serving the emerging fields of translational and personalized medicine. Thermo Scientific Clinical LIMS (laboratory... » read more
Thermo Scientific CLINICAL LIMS – Lab Centric Solutions for Patient Centric Results “One of the... » read more
MPI Research and Perfinity Biosciences are working in partnership to streamline and validate bioanalysis of... » read more
New pharmaceutical products require significant resources from concept to final market introduction. Every step along... » read more
Recently, there has been a heightened public awareness of drug safety across the globe. Nonclinical... » read more
Nonclinical dose formulation analysis (NCDFA) is required in all regulated studies used to assess the... » read more
Stem cells are critical during the development of regenerative cell therapy and migrate to different locations in... » read more
Dyslipidemia is an abnormal amount of lipids such as cholesterol and/or fat in the blood,... » read more
Drug candidates fail for many reasons: poor therapeutic index, poor pharmacokinetics, inadequate physicochemical properties, drug-drug interactions,... » read more
The Scientific Poster Session will run Wednesday, May 4 and Thursday, May 5. 3M will... » read more
The Adesis Catalog of Advanced Heterocycles initiative began in 2003 to support medicinal and combinatorial... » read more
DIA and the Tufts Center for the Study of Drug Development (CSDD) will collaborate on a... » read more
Discovering and developing new drugs is a high risk, high cost and only occasionally high... » read more
“Fail fast, fail early” is a mantra often recited in today’s pharmaceutical and biotechnology industry. Escalating... » read more
